| Literature DB >> 28985439 |
Chunna Yu1,2, Hong Guo1,2, Yangyang Zhang1, Yaobin Song1,3, Erxu Pi1, Chenliang Yu4, Lei Zhang5, Ming Dong1,3, Bingsong Zheng6, Huizhong Wang1,2, Chenjia Shen1,2.
Abstract
Taxol is currently a valuable anticancer drug; however, the accumulated mixture of taxoids can vary greatly among Taxus species. So far, there is very little genomic information for the genus Taxus, except for Taxus baccata. Transcriptome analysis is a powerful approach to explore the different regulatory mechanisms underlying the taxoid biosynthesis pathway in Taxus species. First, we quantified the variation in the taxoid contents between Taxus media and Taxus mairei. The contents of paclitaxel and 10-deacetylpaclitaxel in T. media are higher than that in T. mairei. Then, the transcriptome profiles of T. media and T. mairei were analyzed to investigate the altered expressions. A total of 20,704 significantly differentially expressed genes (DEGs), including 9865 unigenes predominantly expressed in T. media and 10,839 unigenes predominantly expressed in T. mairei, were identified. In total, 120 jasmonic acid-related DEGs were analyzed, suggesting variations in 'response to JA stimulus' and 'JA biosynthetic process' pathways between T. media and T. mairei. Furthermore, a number of genes related to the precursor supply, taxane skeleton formation and hydroxylation, and C13-side chain assembly were also identified. The differential expression of the candidate genes involved in taxoid biosynthetic pathways may explain the variation in the taxoid contents between T. media and T. mairei.Entities:
Keywords: HPLC–MS/MS; Taxol; Taxus; taxoid biosynthetic pathway; transcriptome
Mesh:
Substances:
Year: 2017 PMID: 28985439 DOI: 10.1093/treephys/tpx091
Source DB: PubMed Journal: Tree Physiol ISSN: 0829-318X Impact factor: 4.196